🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Here we go… PCRonline 🫀 London Valves 2023 begins! #PCRLV

#TMVR: the wait will be worth it - panel discussion: ➡️ scientific understanding, progress has been slow; long path ahead ➡️ value proposition is no MR post-op ➡️ MANY devices ▶️ difficultly enrolling patients ➡️ safety profile of TMVR devices is main hurdle PCRonline 🫀 Cardiovascular Research Foundation

The #EAPCI community mourns the sudden loss of Alain Cribier, a pioneering #IC known for numerous 'firsts' including the first-in-man #TAVI on April 16, 2002. Our heartfelt condolences to his family, friends + colleagues. His wisdom, expertise and guidance will be greatly missed.

Congratulations to the winners of ICI Meeting's Innovation Competition and our #Award for #Innovation in #Cardiology !

Back at it: day 1 of #sif2024 with Andrew M. Goldsweig, MD, MS taking us through the top structural trials of 2023. Great to be back! David Rizik, MD Scottsdale Interventional Forum Chadi Alraies, MD FACC FSCAI Molly Szerlip MD John Lasala Matthew Sherwood, MD, MHS SCAI Ankur Gupta MD PhD Alok Sharma megan coylewright md mph Thomas Waggoner Kendra J. Grubb M.D.

One of the best sessions Omar any meeting all year (other meetings take note… conversations/commentary >>> recycled slides). #sif2024 conversations in cardiology with Morton J Kern. #cardiotwitter: thoughts on the topics below? Molly Szerlip MD David Rizik, MD Timothy Henry Scottsdale Interventional Forum

SESAME for LVOT reduction demonstrates amazing ⬇️ in septal thickness and ⬆️ in neoLVOT area. #CRT2024 Late breakers. Great safety profile compared to traditional invasive alternatives.

SIF Conversations with Jonathan Schwartz, MD at Scottsdale Interventional Forum youtu.be/W-SdWJIwfTQ?si… via YouTube

Congrats to Auroa Badin, David DeLurgio, Dr. Devi G Nair, Jonathan Schwartz, MD & Dr. Noah Thormeier for being first in their respective state to use the WATCHMAN TruSteer™ Access System! Check out their photos below👇 Safety info: bit.ly/3YP62GY

Congratulations to the team at Atrium Health!

It’s time… BostonSci Cardiology #Watchman #TruSteer access system finally available! Bidirectional tip articulation + less core wire bias ➡️ huge advance in the #LAAO world to optimize #watchmanFLXpro delivery. First case w/precise positioning 👌🏻 Dr. Devi G Nair Mohamad Alkhouli

First of a kind - How to image T-TEER with 3D ICE, and a novel technique to improve your images without trial and error - the technique to know - 3D Navigation!!! Proud to be part of this amazing group! Abbott Cardiovascular Abbott Philips Healthcare Minneapolis Heart Institute Foundation Cardiovascular Research Foundation Allina Health

When should we start discussing interventional treatment for optimal results? What about valve selection? Will AI impact physician choices? Following the session on early diagnosis and lifetime management of valvular heart disease at #PCRLV, Marcio Montenegro asked Jonathan Schwartz, MD to

Jonathan Schwartz, MD wowing the crowd with a discussion on TR. Atrium Health Sanger Heart & Vascular Institute Amy Winiger, DNP, ACNP-BC, FACC NC Chapter ACC Soc. Chilena de Cardiología

Exposición del Dr. Jonathan Schwartz en módulo de Hemodinamia: "Tratamiento percutáneo de la válvula tricúspide". #CongresoSOCHICAR2024 #Hemodinamia

LBCT American College of Cardiology 2025: 2 year outcomes of the #Triluminate trial for severe #TR: ☑️ TriClip therapy reduced heart failure hospitalizations vs GDMT ☑️ Improvement in TR, QOL sustained in TriClip pts ☑️ TriClip therapy remained safe ☑️ Crossover pts: improved TR severity, QOL

Final day at #ACC25 and our Structual Heart team leads a great session on Advances in Transcatheter Interventions for Tricuspid Regurgitation – Jonathan Schwartz, MD Dr. Jonathon Schwartz, Dr. Holly Gonzales and Cat Shah share new data and early implant experiences. #SangerHeart

The two-year follow-up results of the TRILUMINATE trial indicate a significant reduction in tricuspid regurgitation severity and decreased heart failure hospitalization rates with tricuspid TEER compared... #AHAJournals Samir Kapadia Jonathan Schwartz, MD RTHahnMD ahajrnls.org/3FPQuNW